Cargando…
Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma
BACKGROUND: Biopsy for lung cancer diagnosis is usually done at a single site. But it is unclear that genetic information at one biopsy site represents that of other lesions and is sufficient for therapeutic decision making. METHODS: Non-synonymous mutations and insertions/deletions of 16 genes cont...
Autores principales: | Kim, Eun Young, Cho, Eun Na, Park, Heae Surng, Kim, Arum, Hong, Ji Young, Lim, Seri, Youn, Jong Pil, Hwang, Seung Yong, Chang, Yoon Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717557/ https://www.ncbi.nlm.nih.gov/pubmed/26782967 http://dx.doi.org/10.1186/s12885-016-2049-z |
Ejemplares similares
-
Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
por: Kim, Eun Young, et al.
Publicado: (2016) -
Metastatic Endobronchial Adenocarcinoma from the Uterine Cervix Verified by Human Papillomavirus Genotyping
por: Kim, Jisup, et al.
Publicado: (2015) -
Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015
por: Yeo, Chang Dong, et al.
Publicado: (2018) -
Sarcomatoid urothelial carcinoma arising in the female urethral diverticulum
por: Park, Heae Surng
Publicado: (2021) -
Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
por: Kim, Eun Young, et al.
Publicado: (2018)